Sign in

NCT03802253Active, not recruiting

Time Restricted Eating on Impaired Glucose Regulation(TRIG Trial)

Study to Evaluate the Effects of Time-Restricted Eating Regimen in Overweight/Obese Subjects With Impaired Glucose Regulation

Source: ClinicalTrials.gov · Last updated 13 Apr 2026

Brief summary (registry, in English)

We evaluated the effects of Time-Restricted Eating (TRE) regimen on Impaired Glucose Regulation (IGR) in comparison with overweight/obese patients receiving standard of care over 12 months.

Status (registry)
Active, not recruiting
Study type
Interventional
Enrollment
142 (actual)
First submitted
8 Jan 2019
Start date
4 May 2020
Primary completion date
31 Aug 2025
Lead sponsor
The First Affiliated Hospital of Xiamen University
Diseases
Obesity
NCT number
NCT03802253

What you commit to

  • Study type: Interventional
  • Participants enrolled: 142
  • From 4 May 2020 to the primary completion date, 31 Aug 2025
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Taking medications affecting weight or energy intake/energy expenditure in the last 6 months, including weight loss medications, antipsychotic drugs or other medications as determined by the study physician;

Other illness

  • Active and uncontrolled thyroid diseases (including subjects on thyroid replacement therapy or anti-thyroid drugs) or active endocrine diseases such as Cushing's syndrome or Acromegaly at recruitment
  • History of serious cardiovascular or cerebrovascular disease (angina, myocardial infarction or stroke) in the past 6 months;

Lab values

  • Serious liver dysfunction or chronic kidney disease (AST or ALT \> 3 times the upper limit of normal, or eGFR\<30 ml/min/1.73 m2);

Other

  • Confirmed diagnosis of DM or on hypoglycaemic treatment
  • Women who are pregnant or breast-feeding at recruitment
  • Patients taking glucocorticoid at recruitment
  • Currently participating in weight loss programs or weight change in the past 3 months (\> 5% current body weight) ;
  • Patients who cannot be followed for 24 months (due to a health situation or migration);
  • Patients who are unwilling or unable to give informed consent.

Who the study is looking for

  • Aged ≥ 18 year
  • Diagnosis of impaired glucose regulation (i.e. FG between 5.7-6.9mmol/L) +/- impaired glucose tolerance (i.e. 2-hour postprandial PG between 7.8-11.1mmol/L) confirmed by latest OGTT results within 3 months prior to recruitment
  • Body mass index (BMI)of 23.0 to 45.0 kg/m2;

Age in the registry: 18 years to 70 years · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
The First Affiliated hospital of Xiamen University
Coordinator of this site? Confirm its status
XiamenChinaUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.